Recombinant TIMP1 Protein Human origin (Human Cells) (CAT#: VCoS-Wyb886)
CAT
Size
Price
Quantity
VCoS-Wyb886
For Research Use Only. We do not provide direct services or products for patients.
Product Overview
TIMP Metallopeptidase Inhibitor 1 Protein, Native Protein.
Source
Human Cells
Target
SARS-CoV-2
Type
Inhibitor
Formulation
50 mM Tris-HCl, pH 7, 200 mM NaCl, 5 mM CaCl₂, 1 uM ZnCl₂, 0.05% Brij 35, 0,05% NaN₃.
Purity
>95% pure by SDS-PAGE.
Product Form
Liquid
Storage
Store at -20°C.
Introduction
The 2019 novel coronavirus, or "SARS-CoV-2", was discovered because of Wuhan virus pneumonia cases in 2019, and was named by the World Health Organization on January 12, 2020. It belongs to the beta genera of the Coronaviridae family, together with SARS coronavirus in 2003 and MERS coronavirus in 2012. The alignment between SARS-CoV-2 and 2003 SARS CoV has about 70% sequence similarity and 40% sequence similarity with MERS CoV. The coronavirus genome encodes a spike protein, an envelope protein, a membrane protein, and a nucleoprotein. Among them, spike protein is the most important surface membrane protein of coronavirus.